MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

Aug 2023| BIO115D| BCC Publishing

Report Highlights

The global market for microRNA (miRNA) research tools is estimated to increase from $664.2 million in 2023 to $883.0 million by 2028, at a compound annual growth rate (CAGR) of 5.9% from 2023 through 2028.

Report Includes

  • 33 data tables and 43 additional tables
  • An up-to-date overview and industry analysis of the global markets for microRNA (miRNA) research tools, diagnostics and therapeutics
  • Analyses of the global market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimation of the actual market size and revenue forecast for the global miRNA tools markets, and corresponding market share analysis based on technology type, application (therapeutic area), end user, and region
  • Updated information on key market drivers and opportunities, industry shifts and regulations, and other region and industry specific macroeconomic variables that will influence this market demand in the coming years (2023-2028)
  • Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
  • Review of the selected new miRNA products, research tools and diagnostics services, recent drug candidates, clinical trial applications, and new trends and developments in the biomedical industry
  • Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in various arenas of diagnostics and therapeutics, including cancer, hepatitis infections, and cardiovascular diseases etc.
  • Identification of leading and emerging competitors in the current worldwide market for miRNA research tools, diagnostics, and therapeutics, and analysis of their competitive landscape based on recent developments and segmental revenues
  • Descriptive company profiles of the leading global players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc., F. Hoffmann-La Roche AG, Merck KGaA, Qiagen N.V., and Thermo Fisher Scientific Inc.

Report Scope

The research study aims to thoroughly assess and analyze the miRNA research tools, diagnostics and therapeutics market; revenue forecasts; and future trends globally and provide strategic recommendations for the success of the market participants. This study focuses on the global market of miRNA tools and provides an updated review including its applications in various arenas of diagnostics and therapeutics. The report deals with miRNA tools covering technologies used in the biomedical industry. These products are miRNA quantitative reverse transcription-PCR, next-generation sequencing, microarray, fluorescent in situ hybridization, isolation and purification tools and other tools like inhibitors, probes and vectors.

The report also covers miRNA tools by end user and application. The end users for miRNA tools are categorized as academic and other research institutes, life science industry, and service sectors. The report covers market application areas, such as cancer, cardiovascular diseases, immune diseases, neurological disorders, metabolic disorders, and others (virology, liver diseases, genetic diseases among others).

The scope of the study is global. Current and projected market forecasts during the forecast period (2023 to 2028) are discussed. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by technology type, end user, application and region from 2023 through 2028.

The report also includes an analysis of leading and emerging competitors in the current worldwide miRNA research tools, diagnostics and therapeutics market. Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development, are analyzed to define the specific product strategies employed. This report also assesses emerging trends and technologies in the market.

Frequently Asked Questions (FAQs)

The global miRNA research tools market was valued at $635.6 million in 2022. The market is projected to reach $883.0 million in 2028, growing at a CAGR of 5.9% during the forecast period.
The need for new research tools is constant as users deepen scientific understanding and search for the next breakthrough. MiRNA profiling is fast becoming a promising technique in many research fields, such as translational research. It can provide useful information on the role of miRNAs in the pathogenesis of human diseases such as cancers, metabolic diseases, neurological disorders, and infectious diseases. The miRNA tools market growth is attributed to increased research at the genetic level, increased use of miRNA for therapeutic and diagnostic research purposes, the rise in R&D funding, and increased demand for advanced analysis techniques and assay methods. Microarray technology and the advent of NGS in the early 2000s significantly broadened our understanding of miRNAs and introduced new opportunities for clinical applications.
An in-depth analysis of the global miRNA research tools, diagnostics, and therapeutics market, including historical data and market projection on sales by miRNA tools type, application, end-user, and region.
By type, quantitative reverse transcription polymerase chain reaction (RT-qPCR) will dominate the market by the end of 2028.
Thermo Fisher Scientific, Qiagen N.V., Agilent Technologies Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Merck KGaA, Danaher Corp., Illumina Inc., and others.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023 to 2028
Base year market size $635.6 million
Market size forecast $883.0 million
Growth rate CAGR of 5.9% during 2023-2028 forecast period
Units considered $ Millions
Segments covered By Technology Type, Application, End User, and Geographic Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers
  • Developments in Analytical Technologies and Assay Methods
  • Robust Funding Environment for Biomedical Research
  • Increasing Incidence of Chronic Diseases
  • Growing Number of Clinically Relevant miRNAs
Companies studied
  • F. HOFFMANN-LA ROCHE LTD.
  • GENECOPOEIA INC.
  • ILLUMINA INC.
  • ABCAM PLC
  • AGILENT TECHNOLOGIES INC.
  • BIO-RAD LABORATORIES INC.
  • CD GENOMICS
  • DANAHER CORP.
  • MERCK KGAA
  • NANOSTRING TECHNOLOGIES INC.
  • QIAGEN
  • REGULUS THERAPEUTICS
  • THERMO FISHER SCIENTIFIC INC.
  • TAKARA BIO INC.

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets200Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market Overview15Free
Chapter- 4: Market Dynamics7Free
Chapter- 5: Market Breakdown by Technology Type15Free
Chapter- 6: Market Breakdown by End User23Free
Chapter- 7: Market Breakdown by Application22Free
Chapter- 8: Market Breakdown by Region16Free
Chapter- 9: ESG Development12Free
Chapter- 10: Emerging Trends and Technologies5Free
Chapter- 11: Clinical Trials Analysis7Free
Chapter- 12: Competitive Landscape5Free
Chapter- 13: Company Profiles63Free
Published - Oct-2017| Analyst - Shalini Shahani Dewan| Code - BIO115C

Report Highlights

The global market for microRNA tools reached $756.5 million and $829.8 million in 2015 and 2016, respectively. This market is estimated to reach nearly $1.4 billion in 2021 at a compound annual growth rate (CAGR) of 10.5% for 2016-2021. 

Report Includes

  • An overview of the global market for microRNA diagnostics and therapeutics, with an analysis of the commercial potential of this research field
  • Analyses of global market trends, with data from 2014, 2015, and 2016, and projections of compound annual growth rates (CAGRs) through 2021
  • Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in different areas of medicine, such as cancer, hepatitis infections, and cardiovascular diseases
  • A focus on recent drug candidates, products, deals between different pharmaceutical companies, major participants, and new trends and developments
  • Identification of the main markets for RNA therapeutics
Published - Sep-2014| Analyst - Natana Raj| Code - BIO115B

Report Highlights

The global market for microRNA (miRNA) research tools, services, diagnostics and drug discovery was valued at $478.8 million in 2013. This market is expected to reach $572 million in 2014 and $1 billion in 2019, at a compound annual growth rate (CAGR) of 12.6% for the period of 2014 to 2019.

Report Includes

  • An overview of the global market for microRNA diagnostics and therapeutics with an analysis of the commercial potential of this research field.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in different areas of medicine, such as cancer, HCV infection, and cardiovascular diseases.
  • A focus on recent drug candidates, products, deals between different pharmaceutical companies, major participants, and new trends and developments.
  • Identification of the main markets for RNA therapeutics.
Published - Nov-2012| Analyst - Marianna Tcherpakov| Code - BIO115A

Report Highlights

The global microRNA research tools market was valued at nearly $295.1 million in 2011 and should reach nearly $338.3 million in 2012. Total market value is expected to reach $763 million in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 17.7%.

Report Includes

  • An overview of the global market for microRNA diagnostics and therapeutics with an analysis of the commercial potential of this research field
  • Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in different areas of medicine, such as cancer, HCV infection, and cardiovascular diseases
  • A focus on recent drug candidates, products, deals between different pharmaceutical companies, major participants, and new trends and developments during the last two years
  • Forecasts of the future situation and major drawbacks of the miRNA drug development model and possible solutions for these obstacles, especially in context of drug stability and delivery
  • Identification of the main markets for RNA therapeutics
  • Comprehensive company profiles of major players in the industry.
MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS